Werewolf Therapeutics (HOWL) Short Interest Ratio & Short Volume $1.08 -0.06 (-5.26%) Closing price 04:00 PM EasternExtended Trading$1.08 -0.01 (-0.46%) As of 06:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Werewolf Therapeutics Short Interest DataWerewolf Therapeutics (HOWL) has a short interest of 2.15 million shares, representing 6.49% of the float (the number of shares available for trading by the public). This marks a -4.87% decrease in short interest from the previous month. The short interest ratio (days to cover) is 8.1, indicating that it would take 8.1 days of the average trading volume of 420,817 shares to cover all short positions.Current Short Interest2,150,000 sharesPrevious Short Interest2,260,000 sharesChange Vs. Previous Month-4.87%Dollar Volume Sold Short$1.94 millionShort Interest Ratio8.1 Days to CoverLast Record DateApril 30, 2025Outstanding Shares44,874,000 sharesFloat Size33,120,000 sharesShort Percent of Float6.49%Today's Trading Volume981,108 sharesAverage Trading Volume420,817 sharesToday's Volume Vs. Average233% Short Selling Werewolf Therapeutics? Sign up to receive the latest short interest report for Werewolf Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHOWL Short Interest Over TimeHOWL Days to Cover Over TimeHOWL Percentage of Float Shorted Over Time Werewolf Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20252,150,000 shares $1.94 million -4.9%6.5%8.1 $0.90 4/15/20252,260,000 shares $1.94 million +15.3%6.8%8.8 $0.86 3/31/20251,960,000 shares $1.91 million -2.0%5.9%7.1 $0.97 3/15/20252,000,000 shares $2.40 million +1.5%6.0%7.2 $1.20 2/28/20251,970,000 shares $2.44 million +5.4%6.0%6.6 $1.24 2/15/20251,870,000 shares $2.79 million +4.5%5.7%5.8 $1.49 1/31/20251,790,000 shares $2.40 million -3.8%5.4%4.6 $1.34 1/15/20251,860,000 shares $2.59 million +8.1%5.7%2.9 $1.39 12/31/20241,720,000 shares $2.55 million +13.2%5.2%2.2 $1.48 12/15/20241,520,000 shares $2.51 million +23.6%4.6%2 $1.65 Get the Latest News and Ratings for HOWL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Werewolf Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/20241,230,000 shares $2.46 million -6.1%3.8%1.7 $2.00 11/15/20241,310,000 shares $2.32 million +6.5%4.0%1.9 $1.77 10/31/20241,230,000 shares $3.14 million +58.5%3.8%2 $2.56 10/15/2024776,000 shares $1.56 million -25.4%2.6%1.5 $2.01 9/30/20241,040,000 shares $2.20 million -7.1%3.4%5.6 $2.12 9/15/20241,120,000 shares $2.62 million +3.7%3.7%3.8 $2.34 8/31/20241,080,000 shares $2.33 million +1.9%3.6%3.5 $2.16 8/15/20241,060,000 shares $2.14 million +3.9%3.5%3.3 $2.02 7/31/20241,020,000 shares $2.30 million -2.9%3.4%3.2 $2.25 7/15/20241,050,000 shares $3.00 million +55.1%3.5%3.4 $2.86 6/30/2024677,100 shares $1.65 million +38.8%2.3%2.2 $2.44 6/15/2024487,900 shares $1.47 million +4.0%1.6%2.3 $3.01 5/31/2024469,100 shares $2.43 million +26.1%1.6%2.5 $5.17 5/15/2024372,000 shares $1.80 million -10.3%1.3%2 $4.85 4/30/2024414,500 shares $2.59 million +1.1%1.4%2.2 $6.24 4/15/2024410,100 shares $2.25 million -13.1%1.4%1.7 $5.49 3/31/2024472,000 shares $3.06 million +9.3%1.6%2 $6.48 3/15/2024432,000 shares $2.65 million -7.1%1.6%1.7 $6.14 2/29/2024464,800 shares $3.22 million +5.0%1.7%1.7 $6.92 2/15/2024442,600 shares $2.79 million +101.9%2.0%1.7 $6.30 1/31/2024219,200 shares $1.01 million -11.8%1.0%0.8 $4.63 1/15/2024248,600 shares $1.25 million -13.2%1.1%0.3 $5.04 12/31/2023286,500 shares $1.11 million -4.6%N/A0.3 $3.86 12/15/2023300,200 shares $897,598.00 -27.0%1.3%0.3 $2.99 11/30/2023411,400 shares $1.01 million -20.7%1.8%0.5 $2.45 11/15/2023518,500 shares $1.14 million +62.9%2.3%0.6 $2.20 10/31/2023318,400 shares $796,000.00 +562.0%1.4%0.4 $2.50 10/15/202348,100 shares $111,111.00 +14.3%0.2%1.5 $2.31 9/30/202342,100 shares $90,094.00 +10.8%0.2%1.2 $2.14 9/15/202338,000 shares $97,660.00 -5.0%0.2%1 $2.57You need this much to retire comfortably (Ad)Top analysts are reporting that the average person will need at least $2 million to retire comfortably these days… But when it takes an average of 41 years to turn a $100K of retirement savings into $1 million… The odds are not in our favor… We can’t promise results or guarantee against losses, but there’s no need to go another day without finding out how to target extra income with Jack’s help.But market veteran Jack Carter can show you his TOP way to target extra income every week in this vi 8/31/202340,000 shares $109,600.00 -36.1%0.2%1 $2.74 8/15/202362,600 shares $157,126.00 +37.6%0.3%1.4 $2.51 7/31/202345,500 shares $122,395.00 -18.3%0.2%1.1 $2.69 7/15/202355,700 shares $176,012.00 -10.0%0.3%1.4 $3.16 6/30/202361,900 shares $188,795.00 +36.6%0.3%1.6 $3.05 6/15/202345,300 shares $150,849.00 -22.4%0.2%1.1 $3.33 5/31/202358,400 shares $186,296.00 +14.5%0.3%1.4 $3.19 5/15/202351,000 shares $143,310.00 No Change0.2%1 $2.81 10/31/2022153,500 shares $454,360.00 -1.7%1.0%1.6 $2.96 10/15/2022156,200 shares $657,602.00 -15.5%1.0%1.8 $4.21 9/30/2022184,900 shares $833,899.00 +42.7%N/A2.7 $4.51 9/15/2022129,600 shares $789,264.00 -10.3%0.9%0.9 $6.09 8/31/2022144,500 shares $731,170.00 -23.9%1.0%1 $5.06 8/15/2022189,800 shares $1.09 million -28.5%1.4%1.3 $5.74 7/31/2022265,300 shares $1.21 million -15.1%2.0%1.8 $4.56 7/15/2022312,500 shares $1.47 million -37.7%2.4%1.8 $4.70 6/30/2022501,600 shares $2.05 million -50.8%3.8%1.3 $4.09 6/15/20221,020,000 shares $4.73 million +2.4%7.8%2.6 $4.64 5/31/2022996,100 shares $3.78 million +7.4%7.6%3 $3.79 5/15/2022927,900 shares $4.40 million +1.7%7.1%2.8 $4.74 4/30/2022912,000 shares $4.06 million +19.3%7.0%2.9 $4.45 4/15/2022764,400 shares $3.51 million +76.5%5.8%2.6 $4.59 3/31/2022433,000 shares $1.91 million +6.6%N/A1.5 $4.40 3/15/2022406,200 shares $1.86 million +19.6%3.1%5.5 $4.59 2/28/2022339,600 shares $2.43 million +15.3%2.6%2.8 $7.16 2/15/2022294,500 shares $2.21 million +3.6%2.3%2.4 $7.49 1/31/2022284,200 shares $2.59 million -60.8%2.2%2.3 $9.11 1/15/2022725,100 shares $6.47 million -7.2%N/A0 $8.92 12/31/2021781,700 shares $9.31 million +23.0%6.0%7.4 $11.91 12/15/2021635,300 shares $8.85 million -2.6%4.9%6.6 $13.93 11/30/2021651,900 shares $9.45 million -1.0%N/A14.4 $14.49 11/15/2021658,300 shares $10.52 million -3.2%5.0%26.3 $15.98 10/29/2021680,100 shares $10.66 million +0.0%4.4%32.4 $15.67 10/15/2021680,000 shares $11.61 million +2.5%4.4%34 $17.07 9/30/2021663,300 shares $11.38 million -2.0%4.3%25.5 $17.16 9/15/2021676,600 shares $11.71 million +3.9%4.6%11.3 $17.30 8/31/2021651,400 shares $11.59 million -0.8%4.4%8.7 $17.80 8/13/2021656,400 shares $9.48 million No Change4.4%7 $14.44 HOWL Short Interest - Frequently Asked Questions What is Werewolf Therapeutics' current short interest? Short interest is the volume of Werewolf Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 2,150,000 shares of HOWL short. 6.49% of Werewolf Therapeutics' shares are currently sold short. Learn More on Werewolf Therapeutics' current short interest. What is a good short interest ratio for Werewolf Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HOWL shares currently have a short interest ratio of 8.0. Learn More on Werewolf Therapeutics's short interest ratio. Which institutional investors are shorting Werewolf Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Werewolf Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Werewolf Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.49% of Werewolf Therapeutics' floating shares are currently sold short. Is Werewolf Therapeutics' short interest increasing or decreasing? Werewolf Therapeutics saw a decline in short interest in April. As of April 30th, there was short interest totaling 2,150,000 shares, a decline of 4.9% from the previous total of 2,260,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Werewolf Therapeutics' float size? Werewolf Therapeutics currently has issued a total of 44,874,000 shares. Some of Werewolf Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Werewolf Therapeutics currently has a public float of 33,120,000 shares. How does Werewolf Therapeutics' short interest compare to its competitors? 6.49% of Werewolf Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Werewolf Therapeutics: Design Therapeutics, Inc. (11.47%), enGene Holdings Inc. (0.31%), Kodiak Sciences Inc. (7.42%), Tonix Pharmaceuticals Holding Corp. (14.19%), Cardiff Oncology, Inc. (26.28%), SOPHiA GENETICS SA (0.08%), Voyager Therapeutics, Inc. (5.24%), Y-mAbs Therapeutics, Inc. (8.96%), CARGO Therapeutics, Inc. (18.87%), ADC Therapeutics SA (4.51%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Werewolf Therapeutics stock? Short selling HOWL is an investing strategy that aims to generate trading profit from Werewolf Therapeutics as its price is falling. HOWL shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Werewolf Therapeutics? A short squeeze for Werewolf Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HOWL, which in turn drives the price of the stock up even further. How often is Werewolf Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HOWL, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies DSGN Short Squeeze ENGN Short Squeeze KOD Short Squeeze TNXP Short Squeeze CRDF Short Squeeze SOPH Short Squeeze VYGR Short Squeeze YMAB Short Squeeze CRGX Short Squeeze ADCT Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HOWL) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Werewolf Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Werewolf Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
